These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12744737)
1. Aberrant expression and deletion of FHIT gene in leukemias. Wang L; Dong LJ; Tian F; Liu GX; Li CH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737 [TBL] [Abstract][Full Text] [Related]
2. Frequent aberration of FHIT gene expression in acute leukemias. Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330 [TBL] [Abstract][Full Text] [Related]
3. Decreased or altered expression of the FHIT gene in human leukemias. Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma. Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452 [TBL] [Abstract][Full Text] [Related]
5. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
7. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
8. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
9. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma. Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140 [TBL] [Abstract][Full Text] [Related]
10. Aberrant FHIT transcripts in human colorectal cancers. Lee SH; Lee SH Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086 [TBL] [Abstract][Full Text] [Related]
11. [FHIT gene is abnormal in Chinese lung cancers]. Zhang J; Fu W; Zhang X Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):592-5. PubMed ID: 11715406 [TBL] [Abstract][Full Text] [Related]
12. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration]. Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436 [TBL] [Abstract][Full Text] [Related]
13. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. Peters UR; Hasse U; Oppliger E; Tschan M; Ong ST; Rassool FV; Borisch B; Tobler A; Fey MF Oncogene; 1999 Jan; 18(1):79-85. PubMed ID: 9926922 [TBL] [Abstract][Full Text] [Related]
14. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines]. Lee SH; Kim HS Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704 [TBL] [Abstract][Full Text] [Related]
15. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
16. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
17. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422 [TBL] [Abstract][Full Text] [Related]
18. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells. Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645 [TBL] [Abstract][Full Text] [Related]
19. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia. Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281 [TBL] [Abstract][Full Text] [Related]
20. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas. Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]